Policy / Regulatory

NHSA Launches Service Specifications for Medical Procurement Platform

Policy / Regulatory

China’s NHC Unveils 2024 Goals for Medical Quality and Safety Improvement

Company

WuXi Biologics Achieves Full-Scale Manufacturing Milestone at Ireland Facility

CompanyDeals

HitGen Inc. and Bostal Drug Delivery Form Strategic Partnership to Advance Nucleic Acid Drug Development

CompanyDeals

Novartis and Fudan University Shanghai Cancer Center Renew Partnership to Drive Precision Cancer Treatments

CompanyDeals

Rebecca Tech Secures USD 10 Million in Series A++ Funding to Expand Micro RF Technology Globally

Company

Jiangsu Hengrui Receives Chinese Approval for First Domestic Category 1 Opioid Analgesic for Postoperative Pain

CompanyMedical Device

Acotec Scientific’s Peridge Catheter Receives NMPA Nod for Hemodialysis Lesion Treatment

CompanyDrug

Beijing Tiantan Biological Halts Phase III Clinical Trial for CMV Immunoglobulin Citing Strategic Reasons

Company

WuXi XDC Forecasts Over 100% Revenue Growth for 2023 on Strength of ADC Industry

Company

GSK Posts 5% YOY Growth in 2023 Financials, Vaccines Business Drives Expansion

Company

Novartis Sees Robust Growth in Innovative Medicines with 2023 Financials Reflecting a Shift Toward R&D Focus